YM087
087-CL-027
Phase 3 small_molecule completed
Quick answer
YM087 for Hyponatremia is a Phase 3 program (small_molecule) at CUMBERLAND PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CUMBERLAND PHARMACEUTICALS INC
- Indication
- Hyponatremia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed